文献速递胃肠外科围术期管理与 ERAS

肌脂肪变性预测胃癌根治术后预后:大样本队列倾向评分匹配分析

Myosteatosis predicts prognosis after radical gastrectomy for gastric cancer: A propensity score-matched analysis from a large-scale cohort.
PubMed 文献 · Surgery · 2019-05-06

本研究基于2008至2013年前瞻性数据库,纳入973例接受择期胃癌根治术且有CT图像的患者,以最优分层法确定肌脂肪变性 cutoff 值,并行1:1倾向评分匹配。匹配后584例分析显示,肌脂肪变性组严重术后并发症率更高、总生存和无病生存更短;多因素分析提示肌脂肪变性是严重并发症的独立危险因素,也是总生存和无病生存缩短的独立预测因素。同时存在肌少症和肌脂肪变性的患者预后最差。

要点

  • 肌脂肪变性增加胃癌根治术后严重并发症风险。
  • 肌脂肪变性是总生存和无病生存缩短的独立预测因素。
  • 肌少症合并肌脂肪变性患者预后最差。

核心结论

  • 胃癌患者肌脂肪变性与不良预后相关。
  • 将骨骼肌按放射密度分亚组有助于理解骨骼肌对胃癌手术不良结局的影响。

研究设计与样本

  • 前瞻性收集2008至2013年接受择期胃癌根治术且有CT图像的患者。
  • 共973例患者,按最优分层法所得cutoff值诊断肌脂肪变性。
  • 采用1:1倾向评分匹配,匹配后584例纳入分析。

主要发现

  • 匹配后肌脂肪变性组严重术后并发症率显著高于非肌脂肪变性组。
  • 匹配后肌脂肪变性组总生存和无病生存均显著短于非肌脂肪变性组。
  • 匹配前多因素分析显示肌脂肪变性是严重术后并发症的独立危险因素。
  • 匹配前Cox比例风险模型显示肌脂肪变性是总生存和无病生存缩短的独立预测因素。
  • 亚组分析显示同时存在肌少症和肌脂肪变性的患者总生存和无病生存较其他患者更差。

临床怎么用

  • 可利用术前CT评估骨骼肌放射密度以识别肌脂肪变性。
  • 对肌脂肪变性患者应加强围术期风险评估与术后并发症防范。
  • 肌脂肪变性合并肌少症患者可能需更密切的术后随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Increasing evidence has suggested that sarcopenia is linked with cancer prognosis, but only limited data have focused on the impact of myosteatosis on cancer outcomes. This study evaluates the influence of myosteatosis on postoperative complications and survival in those patients who underwent radical resection of gastric carcinoma. METHODS: Patients who underwent elective radical gastrectomy for gastric cancer and had computed tomographic images available were identified from a prospectively collected database between 2008 and 2013. Myosteatosis was diagnosed by the cutoff values obtained from the method of optimum stratification. To obtain 2 well-balanced cohorts for available variables influencing clinical outcomes, the myosteatosis group was matched 1:1 with nonmyosteatosis group by using a propensity score match. RESULTS: Of 973 patients, 584 were matched for analyses. Compared with the nonmyosteatosis group, the myosteatosis group manifested significantly higher severe postoperative complications rates, shorter overall survival, and disease-free survival. Before matching, multivariate analyses identified that myosteatosis was an independent risk factor for severe postoperative complications, and Cox proportions hazards model showed that myosteatosis was an independent predictor for shorter overall survival and disease-free survival. In addition, subgroup analyses of each muscle phenotype showed that patients with both sarcopenia and myosteatosis had a poorer overall survival and disease-free survival than other patients. CONCLUSION: Myosteatosis in gastric cancer is associated with poor prognosis. Classifying the skeletal muscle into subranges of radio density is a promising strategy to understand the impact of skeletal muscle on unfavorable surgical outcomes in gastric cancer patients.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Zhuang CL, Shen X, Huang YY, et al. Myosteatosis predicts prognosis after radical gastrectomy for gastric cancer: A propensity score-matched analysis from a large-scale cohort. Surgery. 2019. PMID: 31072665. doi:10.1016/j.surg.2019.03.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。